GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40)

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40). / Ekberg, Jeppe H; Pedersen, Maria Hauge; Kristensen, Line V; Madsen, Andreas N; Engelstoft, Maja S; Husted, Anna-Sofie; Sichlau, Rasmus; Egerod, Kristoffer L; Timshel, Pascal; Kowalski, Timothy J; Gribble, Fiona M; Reiman, Frank; Hansen, Harald S; Howard, Andrew D; Holst, Birgitte; Schwartz, Thue W.

In: Endocrinology, Vol. 157, No. 12, en20161334, 25.10.2016, p. 4561-4569.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ekberg, JH, Pedersen, MH, Kristensen, LV, Madsen, AN, Engelstoft, MS, Husted, A-S, Sichlau, R, Egerod, KL, Timshel, P, Kowalski, TJ, Gribble, FM, Reiman, F, Hansen, HS, Howard, AD, Holst, B & Schwartz, TW 2016, 'GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40)', Endocrinology, vol. 157, no. 12, en20161334, pp. 4561-4569. https://doi.org/10.1210/en.2016-1334

APA

Ekberg, J. H., Pedersen, M. H., Kristensen, L. V., Madsen, A. N., Engelstoft, M. S., Husted, A-S., Sichlau, R., Egerod, K. L., Timshel, P., Kowalski, T. J., Gribble, F. M., Reiman, F., Hansen, H. S., Howard, A. D., Holst, B., & Schwartz, T. W. (2016). GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40). Endocrinology, 157(12), 4561-4569. [en20161334]. https://doi.org/10.1210/en.2016-1334

Vancouver

Ekberg JH, Pedersen MH, Kristensen LV, Madsen AN, Engelstoft MS, Husted A-S et al. GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40). Endocrinology. 2016 Oct 25;157(12):4561-4569. en20161334. https://doi.org/10.1210/en.2016-1334

Author

Ekberg, Jeppe H ; Pedersen, Maria Hauge ; Kristensen, Line V ; Madsen, Andreas N ; Engelstoft, Maja S ; Husted, Anna-Sofie ; Sichlau, Rasmus ; Egerod, Kristoffer L ; Timshel, Pascal ; Kowalski, Timothy J ; Gribble, Fiona M ; Reiman, Frank ; Hansen, Harald S ; Howard, Andrew D ; Holst, Birgitte ; Schwartz, Thue W. / GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40). In: Endocrinology. 2016 ; Vol. 157, No. 12. pp. 4561-4569.

Bibtex

@article{a7118a554c39406caa1d393503961f66,
title = "GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40)",
abstract = "Triglycerides are among the most efficacious stimulators of incretin secretion; however the relative importance of FFA1 (GPR40), FFA4 (GPR120) and GPR119 which all recognize triglyceride metabolites, i.e. LCFA and 2-MAG respectively, is still unclear. Here, we find all three receptors to be highly expressed and highly enriched in FACS-purified GLP-1 and GIP cells isolated from transgenic reporter mice. In vivo, the triglyceride-induced increase in plasma GIP was significantly reduced in FFA1 deficient mice (to 34% - mean of four experiments each with 8-10 animals), in GPR119 deficient mice (to 24 %) and in FFA1/FFA4 double deficient mice (to 15%) but not in FFA4 deficient mice. The triglyceride-induced increase in plasma GLP-1 was only significantly reduced in the GPR119 deficient and the FFA1/FFA4 double deficient mice, but not in the FFA1 and FFA4 deficient mice. In mouse colonic crypt cultures the synthetic FFA1 agonists, TAK-875 stimulated GLP-1 secretion to a similar extent as the prototype GLP-1 secretagogue neuromedin C, this however only corresponded to approx. half the maximal efficiency of the GPR119 agonist AR231453 whereas the GPR120 agonist Metabolix-209 had no effect. Importantly, when the FFA1 agonist was administered on top of appropriately low doses of the GPR119 agonist a clear synergistic, i.e. more than additive effect was observed. It is concluded that the 2-MAG receptor GPR119 is at least as important as the LCFA receptor FFA1 in mediating the triglyceride-induced secretion of incretins and that the two receptors act in synergy whereas FFA4 plays a minor if any role.",
author = "Ekberg, {Jeppe H} and Pedersen, {Maria Hauge} and Kristensen, {Line V} and Madsen, {Andreas N} and Engelstoft, {Maja S} and Anna-Sofie Husted and Rasmus Sichlau and Egerod, {Kristoffer L} and Pascal Timshel and Kowalski, {Timothy J} and Gribble, {Fiona M} and Frank Reiman and Hansen, {Harald S} and Howard, {Andrew D} and Birgitte Holst and Schwartz, {Thue W}",
year = "2016",
month = oct,
day = "25",
doi = "10.1210/en.2016-1334",
language = "English",
volume = "157",
pages = "4561--4569",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0013-7227",
publisher = "Oxford University Press",
number = "12",

}

RIS

TY - JOUR

T1 - GPR119 - a major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Co-acting in Synergy with FFA1 (GPR40)

AU - Ekberg, Jeppe H

AU - Pedersen, Maria Hauge

AU - Kristensen, Line V

AU - Madsen, Andreas N

AU - Engelstoft, Maja S

AU - Husted, Anna-Sofie

AU - Sichlau, Rasmus

AU - Egerod, Kristoffer L

AU - Timshel, Pascal

AU - Kowalski, Timothy J

AU - Gribble, Fiona M

AU - Reiman, Frank

AU - Hansen, Harald S

AU - Howard, Andrew D

AU - Holst, Birgitte

AU - Schwartz, Thue W

PY - 2016/10/25

Y1 - 2016/10/25

N2 - Triglycerides are among the most efficacious stimulators of incretin secretion; however the relative importance of FFA1 (GPR40), FFA4 (GPR120) and GPR119 which all recognize triglyceride metabolites, i.e. LCFA and 2-MAG respectively, is still unclear. Here, we find all three receptors to be highly expressed and highly enriched in FACS-purified GLP-1 and GIP cells isolated from transgenic reporter mice. In vivo, the triglyceride-induced increase in plasma GIP was significantly reduced in FFA1 deficient mice (to 34% - mean of four experiments each with 8-10 animals), in GPR119 deficient mice (to 24 %) and in FFA1/FFA4 double deficient mice (to 15%) but not in FFA4 deficient mice. The triglyceride-induced increase in plasma GLP-1 was only significantly reduced in the GPR119 deficient and the FFA1/FFA4 double deficient mice, but not in the FFA1 and FFA4 deficient mice. In mouse colonic crypt cultures the synthetic FFA1 agonists, TAK-875 stimulated GLP-1 secretion to a similar extent as the prototype GLP-1 secretagogue neuromedin C, this however only corresponded to approx. half the maximal efficiency of the GPR119 agonist AR231453 whereas the GPR120 agonist Metabolix-209 had no effect. Importantly, when the FFA1 agonist was administered on top of appropriately low doses of the GPR119 agonist a clear synergistic, i.e. more than additive effect was observed. It is concluded that the 2-MAG receptor GPR119 is at least as important as the LCFA receptor FFA1 in mediating the triglyceride-induced secretion of incretins and that the two receptors act in synergy whereas FFA4 plays a minor if any role.

AB - Triglycerides are among the most efficacious stimulators of incretin secretion; however the relative importance of FFA1 (GPR40), FFA4 (GPR120) and GPR119 which all recognize triglyceride metabolites, i.e. LCFA and 2-MAG respectively, is still unclear. Here, we find all three receptors to be highly expressed and highly enriched in FACS-purified GLP-1 and GIP cells isolated from transgenic reporter mice. In vivo, the triglyceride-induced increase in plasma GIP was significantly reduced in FFA1 deficient mice (to 34% - mean of four experiments each with 8-10 animals), in GPR119 deficient mice (to 24 %) and in FFA1/FFA4 double deficient mice (to 15%) but not in FFA4 deficient mice. The triglyceride-induced increase in plasma GLP-1 was only significantly reduced in the GPR119 deficient and the FFA1/FFA4 double deficient mice, but not in the FFA1 and FFA4 deficient mice. In mouse colonic crypt cultures the synthetic FFA1 agonists, TAK-875 stimulated GLP-1 secretion to a similar extent as the prototype GLP-1 secretagogue neuromedin C, this however only corresponded to approx. half the maximal efficiency of the GPR119 agonist AR231453 whereas the GPR120 agonist Metabolix-209 had no effect. Importantly, when the FFA1 agonist was administered on top of appropriately low doses of the GPR119 agonist a clear synergistic, i.e. more than additive effect was observed. It is concluded that the 2-MAG receptor GPR119 is at least as important as the LCFA receptor FFA1 in mediating the triglyceride-induced secretion of incretins and that the two receptors act in synergy whereas FFA4 plays a minor if any role.

U2 - 10.1210/en.2016-1334

DO - 10.1210/en.2016-1334

M3 - Journal article

C2 - 27779915

VL - 157

SP - 4561

EP - 4569

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0013-7227

IS - 12

M1 - en20161334

ER -

ID: 169562929